Literature DB >> 10511609

Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.

H U Simon1, S G Plötz, R Dummer, K Blaser.   

Abstract

BACKGROUND: The cause of persistent eosinophilia and the hypereosinophilic syndrome is unknown. Recent work suggests that in some patients with the hypereosinophilic syndrome, a clone of abnormal T cells produces large amounts of interleukin-5, a cytokine required for the growth and differentiation of eosinophils. We examined T-cell surface markers, rearranged T-cell-receptor genes, and in vitro production of cytokines by T cells from patients with idiopathic eosinophilia.
METHODS: The expression of surface molecules on T cells was measured by flow cytometry. Cytokine expression was measured by enzyme-linked immunosorbent assay, flow cytometry, and immunohistochemical analysis. To identify dominant (clonal) rearrangements of the T-cell receptor within the lymphocyte population, Southern blot analysis (beta chain) and the polymerase chain reaction (gamma chain) were performed according to standard protocols.
RESULTS: Among 60 patients with idiopathic eosinophilia, 16 had circulating T cells with an aberrant immunophenotype. In each of these patients, the abnormal immunophenotype was unique. Evidence of clonal rearrangements of the T-cell receptor was obtained in 8 of the 16 patients. In most instances, the abnormal T cells expressed large amounts of surface proteins associated with T-cell activation (the alpha chain of the interleukin-2 receptor and the HLA-DR antigen). Moreover, the aberrant T cells produced large amounts of interleukin-5 in vitro.
CONCLUSIONS: Clonal populations of abnormal T cells producing interleukin-5 occur in some patients with idiopathic eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511609     DOI: 10.1056/NEJM199910073411503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  68 in total

1.  A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.

Authors:  Isabelle Delèvaux; Marc André; Jacques Chipponi; Anne-Marie Milési-Lecat; P Déchelotte; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

2.  BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.

Authors:  Yorick Sandberg; Ellen J van Gastel-Mol; Brenda Verhaaf; King H Lam; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

Review 3.  [Anti-interleukin-5 therapy for eosinophilic diseases].

Authors:  D Simon; L R Braathen; H-U Simon
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

4.  Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Authors:  Masahiko Sumi; Kosuke Nunoda; Tomonori Mizutani; Yuko Ishii; Akihiko Gotoh; Yukihiko Kimura; Yasuhiro Suga; Tatsuo Ohira; Kuniharu Miyajima; Hiromi Serizawa; Kiyoshi Mukai; Harubumi Kato; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

Review 5.  Advances in diagnosis and treatment of eosinophilia.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

6.  The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.

Authors:  Yoshiyuki Yamada; Marc E Rothenberg; Andrew W Lee; Hiroko Saito Akei; Eric B Brandt; David A Williams; Jose A Cancelas
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 7.  Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations.

Authors:  Florence Roufosse
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 8.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

9.  FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells.

Authors:  Kentaro Fukushima; Itaru Matsumura; Sachiko Ezoe; Masahiro Tokunaga; Masato Yasumi; Yusuke Satoh; Hirohiko Shibayama; Hirokazu Tanaka; Atsushi Iwama; Yuzuru Kanakura
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

Review 10.  Adult eosinophilic gastroenteritis and hypereosinophilic syndromes.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.